Generic placeholder image

Current Nutrition & Food Science

Editor-in-Chief

ISSN (Print): 1573-4013
ISSN (Online): 2212-3881

Research Article

Evaluation of the Effects of Zn/Mg Supplemented Diet as Adjuvant Therapy with Glibenclamide on Streptozotocin-induced Diabetic Rats

Author(s): Anoop Singh Negi, Veerma Ram*, Lata Bisht, Rajnish Kumar, Ankit Kumar, Atal Bihari Bajpai and Deepak Kumar Semwal*

Volume 18, Issue 6, 2022

Published on: 21 April, 2022

Page: [597 - 603] Pages: 7

DOI: 10.2174/1573401318666220304151421

Price: $65

conference banner
Abstract

Background: Diabetes mellitus (DM), a metabolic disorder mainly characterized by hyperglycemia, causes the damage of various organs, including the eyes, liver, kidney and heart. It is evident that diet plays a key role in the management of DM.

Objective: The present study aimed to evaluate the effect of Zn and Mg supplemented diets as an adjuvant therapy with glibenclamide on streptozotocin (STZ)-induced diabetic rats.

Methods: The rats which showed a blood glucose level of 200 mg/dL or higher after 48 h of STZ injection were considered as diabetic. The rats were divided into eight groups in which the normal control group comprised non-diabetic rats, whereas the rest of the groups had diabetic rats in which glibenclamide (5 mg/kg) with an ordinary diet was given to the positive control group while the test groups were treated with glibenclamide along with specific diets. Blood glucose, body weight and lipid profile, as well as the liver and kidney functions were evaluated using standard kits after a certain interval up to 21 days.

Results: Glibenclamide at different doses with or without Zn and Mg significantly decreased blood glucose, cholesterol, triglyceride, urea, creatinine, total bilirubin and LDL levels, whereas it increased the HDL level. The study revealed glibenclamide together with Zn and Mg-rich diet to provide the most significant (p <0.0001) results.

Conclusion: The treatment of diabetes mellitus with glibenclamide can provide better results if it is used with Zn and Mg-rich diet, which can prove to be a potential adjuvant therapy for type-2 diabetes and its associated complications.

Keywords: Biochemical analysis, creatinine, diabetes mellitus, hyperglycaemia, total bilirubin, adjuvant therapy.

« Previous
Graphical Abstract

[1]
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2009; 32(Suppl. 1): S62-7.
[http://dx.doi.org/10.2337/dc09-S062] [PMID: 19118289]
[2]
Kumar A, Aswal S, Semwal RB, Chauhan A, Joshi SK, Semwal DK. Role of plant-derived alkaloids against diabetes and diabetes-related complications: A mechanism-based approach. Phytochem Rev 2019; 18: 1277-98.
[http://dx.doi.org/10.1007/s11101-019-09648-6]
[3]
Goldenberg R, Punthakee Z. Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome. Can J Diabetes 2013; 37(Suppl. 1): S8-S11.
[http://dx.doi.org/10.1016/j.jcjd.2013.01.011] [PMID: 24070969]
[4]
Roth HP, Kirchgessner M. Zinc and insulin metabolism. Biol Trace Elem Res 1981; 3(1): 13-32.
[http://dx.doi.org/10.1007/BF02789121] [PMID: 24271559]
[5]
Mooradian AD, Morley JE. Micronutrient status in diabetes mellitus. Am J Clin Nutr 1987; 45(5): 877-95.
[http://dx.doi.org/10.1093/ajcn/45.5.877] [PMID: 3554960]
[6]
Kruse-Jarres JD, Rükgauer M. Trace elements in diabetes mellitus. Peculiarities and clinical validity of determinations in blood cells. J Trace Elem Med Biol 2000; 14(1): 21-7.
[http://dx.doi.org/10.1016/S0946-672X(00)80019-X] [PMID: 10836530]
[7]
Kostov K. Effects of magnesium deficiency on mechanisms of insulin resistance in type 2 diabetes: Focusing on the processes of insulin secretion and signaling. Int J Mol Sci 2019; 20(6): 1351.
[http://dx.doi.org/10.3390/ijms20061351] [PMID: 30889804]
[8]
Del Gobbo LC, Song Y, Poirier P, Dewailly E, Elin RJ, Egeland GM. Low serum magnesium concentrations are associated with a high prevalence of premature ventricular complexes in obese adults with type 2 diabetes. Cardiovasc Diabetol 2012; 11: 23.
[http://dx.doi.org/10.1186/1475-2840-11-23] [PMID: 22405520]
[9]
Fukunaka A, Fujitani Y. Role of zinc homeostasis in the pathogenesis of diabetes and obesity. Int J Mol Sci 2018; 19(2): 476.
[http://dx.doi.org/10.3390/ijms19020476] [PMID: 29415457]
[10]
Lorenzati B, Zucco C, Miglietta S, Lamberti F, Bruno G. Oral hypoglycemic drugs: Pathophysiological basis of their mechanism of action. Pharmaceuticals (Basel) 2010; 3(9): 3005-20.
[http://dx.doi.org/10.3390/ph3093005] [PMID: 27713388]
[11]
Romero AC, Ibuki FK, Nogueira FN. Sialic acid reduction in the saliva of streptozotocin induced diabetic rats. Arch Oral Biol 2012; 57(9): 1189-93.
[http://dx.doi.org/10.1016/j.archoralbio.2012.02.016] [PMID: 22421632]
[12]
Trinder P. Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J Clin Pathol 1969; 22(2): 158-61.
[http://dx.doi.org/10.1136/jcp.22.2.158] [PMID: 5776547]
[13]
Castelli WP, Doyle JT, Gordon T, et al. HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study. Circulation 1977; 55(5): 767-72.
[http://dx.doi.org/10.1161/01.CIR.55.5.767] [PMID: 191215]
[14]
Safhi MM, Alam MF, Sivakumar SM, Anwer T. Hepatoprotective potential of Sargassum muticum against STZ-induced diabetic liver damage in wistar rats by inhibiting cytokines and the apoptosis pathway. Anal Cell Pathol (Amst) 2019; 2019: 7958701.
[http://dx.doi.org/10.1155/2019/7958701] [PMID: 30937278]
[15]
Dickerman B, Liu J. Do the micronutrients zinc and magnesium play a role in adult depression? Topics Clin Nutr 2011; 26(3): 257-67.
[http://dx.doi.org/10.1097/TIN.0b013e3182260d86] [PMID: 29151671]
[16]
Jayawardena R, Ranasinghe P, Galappatthy P, Malkanthi R, Constantine G, Katulanda P. Effects of zinc supplementation on diabetes mellitus: A systematic review and meta-analysis. Diabetol Metab Syndr 2012; 4(1): 13.
[http://dx.doi.org/10.1186/1758-5996-4-13] [PMID: 22515411]
[17]
Masood N, Baloch GH, Ghori RA, Memon IA, Memon MA, Memon MS. Serum zinc and magnesium in type-2 diabetic patients. J Coll Physicians Surg Pak 2009; 19(8): 483-6.
[PMID: 19651009]
[18]
Miller NE, Thelle DS, Forde OH, Mjos OD. The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: A prospective case-control study. Lancet 1977; 1(8019): 965-8.
[http://dx.doi.org/10.1016/S0140-6736(77)92274-7] [PMID: 67464]
[19]
Giannini EG, Testa R, Savarino V. Liver enzyme alteration: A guide for clinicians. CMAJ 2005; 172(3): 367-79.
[http://dx.doi.org/10.1503/cmaj.1040752] [PMID: 15684121]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy